Curofy
Sublingual immunotherapy for allergy-related asthma
Immunotherapy using sublingual tablets containing house dust mite allergen extended the interval until patients developed a moderate asthma exacerbation in a manufacturer-sponsored clinical trial reported online in JAMA.
See this content immediately after install